Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
1(33.3%)
Phase 2
1(33.3%)
Phase 4
1(33.3%)
3Total
N/A(1)
Phase 2(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT00699413Phase 4Terminated

Supplements for Controlling Resistance to Insulin

Role: collaborator

NCT04782024Phase 2Completed

A Study to Investigate the Effect of 7-Keto on Resting Metabolic Rate in Overweight Adults

Role: collaborator

NCT02734251Not ApplicableCompleted

Effect of Relora Supplement on Anxiety, Cognitive Performance & Mood Tested After Induced Stress

Role: lead

All 3 trials loaded